Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Clinical trial NCT05198856 · UNKNOWN
Trial details
- NCT number
- NCT05198856
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2024-03-10
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.